𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Concentration of rivastigmine and its metabolite to the therapeutic response in Alzheimer's disease

✍ Scribed by Yang, Yuan-Han; Chou, Mei-Chuan; Chen, Chun-Hung; Liu, Ching-Kuan

Book ID
123506500
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
52 KB
Volume
7
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rivastigmine transdermal patch and capsu
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy
✍ Martin R. Farlow; George T. Grossberg; Xiangyi Meng; Jason Olin; Monique Somogyi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 373 KB

## Abstract ## Objectives The cholinesterase inhibitor rivastigmine is approved for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). This exploratory, hypothesis‐forming analysis assessed response to rivastigmine according to severity of dementia at baseline. ## Methods Th